US Stock MarketDetailed Quotes

MIRA MIRA Pharmaceuticals

Watchlist

1.100
+0.050+4.76%

Close Oct 16 16:00 ET

1.070
-0.030-2.73%

Post 17:46 ET

17.89MMarket Cap-1307P/E (TTM)

MIRA Pharmaceuticals Stock Forum

DamYankee

Oct 11 05:03

$MIRA Pharmaceuticals (MIRA.US)$ I hope this pulls back up again. I'm in at 1.48 average

Teddy123

Sep 30 09:02

About time

$MIRA Pharmaceuticals (MIRA.US)$

Teddy123

Sep 30 00:26

Mira Pharma Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024Louis JuricicAuthorLouis JuricicPublished 09/27/202

$MIRA Pharmaceuticals (MIRA.US)$
investing.com/n...

Stock_Drift

Sep 27 10:37

Nice. 🤝

$MIRA Pharmaceuticals (MIRA.US)$

DEVACREATION7

Sep 27 10:25

$MIRA Pharmaceuticals (MIRA.US)$ loading...

TheOracleOfHindSight

Sep 27 09:41

😜Tough to Swing when… (+25%)

$Venus Concept (VERO.US)$ When im watching my Chinese Calls..! 🕺🕺But between this & $MIRA Pharmaceuticals (MIRA.US)$ had a fine morning! Thank you @Stock_Drift & @jaguar8 wherever u are today for getting up early & keeping me interested! ❤️❤️

Stock_Drift

Sep 27 06:41

$MIRA Pharmaceuticals (MIRA.US)$

Jaguar8

Sep 27 06:37

NEWS

$MIRA Pharmaceuticals (MIRA.US)$
MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024
Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic pain
MIAMI, FL / ACCESSWIRE / September 27, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company developing innovative therapies for neurologic and neu...